1-4 of 4
Bhavesh Shah
Close
Sort by
Journal Articles

Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis

David Hughes, PharmD, Radhika Jhaveri, PharmD, Bhavesh Shah, RPh, Frances Blevins, PA-C, Alexamil Rodriguez, CPhT, Shayna Sarosiek, MD, Adam Lerner, MD, John Mark Sloan, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-135992
Published: 2020
Journal Articles

Successful Transition from Bortezomib Subcutaneous (SubQ) to Generic Intravenous (IV) Bortezomib: Cost Savings Initiative with Global Economic Impact

Radhika Jhaveri, PharmD, Vaishali Sanchorawala, MD, John Mark Sloan, MD, Adam Lerner, MD, Shayna Sarosiek, Bhavesh Shah, RPh
Journal: Blood
Blood (2019) 134 (Supplement_1): 4758.
https://doi.org/10.1182/blood-2019-128992
Published: 2019
Journal Articles

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4912.
https://doi.org/10.1182/blood-2019-124740
Published: 2019
Journal Articles

A Retrospective Review of Engraftment Data for Tbo-Filgrastim Vs. Filgrastim in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation

Taylor Teschner, Stephen Lo, Dina Brauneis, Anthony C Shelton, Bhavesh Shah, John Mark Sloan, Cindy Varga, Karen Quillen, Vaishali Sanchorawala
Journal: Blood
Blood (2015) 126 (23): 5484.
https://doi.org/10.1182/blood.V126.23.5484.5484
Published: 2015